Tag Archives: InVivo Therapeutics

InVivo Therapeutics restructures and suspends chronic SCI stem cell and gene therapy research programs

CAMBRIDGE, Mass. (August 28, 2017) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that it is executing a strategic restructuring in order to focus on The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Spinal Research, Stem Cell Research | Tagged | 2 Comments

InVivo Therapeutics at Meeting on the Mesa

InVivo Therapeutics Video Presentation at Alliance for Regenerative Medicine 6th Annual Partnering Forum Tom Ulich, M.D., Chief Scientific Officer, Cambridge, MA (NASDAQ: NVIV)

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research | Tagged , ,

Robert Langer explains polymer scaffold/neural stem cell combo for SCI at NAE

Robert S. Langer David H. Kock Institute Professor Massachusetts Institute of Technology NAE Annual Meeting 2015, plenary speaker The Langer Lab LINK National Academy of Engineering

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged ,

InVivo Therapeutics update on preclinical Bioengineered Neural Trails™ for chronic SCI

This short video explains the “preclinical” stage work at InVivo for chronic SCI. Read about the newly announced patents HERE InVivo Pipeline Information LINK We are devoting significant resources to advancing our Bioengineered Neural Trails program for the 276,000 patients … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Rehabilitation, Spinal Research, Stem Cell Research | Tagged , ,

InVivo announces treatment patents for chronic SCI on Bioengineered Neural Trails™

InVivo Therapeutics Announces Bioengineered Neural Trails™ Program for Chronic Spinal Cord Injury New Intellectual Property to Support Minimally Invasive Transplantation of Trails of Neural Stem Cells – Executed Agreements with University of California, San Diego and Dr. James Guest – … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research | Tagged

Alliance for Regenerative Medicine: Stem Cells 2014

Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Spinal Research, Stem Cell Research | Tagged , , , ,

InVivo Therapeutics Begins First Clinical Trial of Neuro-Spinal Scaffold –

InVivo Therapeutics has begun shipment of its innovative investigational device, a degradable polymer Neuro-Spinal Scaffold for spinal cord injury (SCI) patients, for initiation of the company’s first clinical trial. InVivo has pioneered a new treatment platform utilizing a biocompatible polymer-based … Continue reading

Posted in Biomaterials, Chronic Spinal Cord Injury Research, Spinal Research, Unite 2 Fight Paralysis, Working 2 Walk Science & Advocacy Symposium | Tagged ,